vTv Therapeutics VTVT
NASDAQ VTVT
$31.85 +1.01 (+3.27%)
At close: Oct 1, 2026 · 4:00 PM EDT

vTv Therapeutics (VTVT) Liabilities and Shareholders Equity (2014 - 2026)

Updated

vTv Therapeutics (VTVT) recorded Liabilities and Shareholders Equity of $87.59 million in Q2 2026, up 231.2% from $26.45 million a year earlier but down 11.4% from the prior quarter.

Analysis

vTv Therapeutics (VTVT) Liabilities and Shareholders Equity (2014 - 2026) Analysis & Trends

At the end of FY2025, vTv Therapeutics reported Liabilities and Shareholders Equity of $89.9 million, up 134.9% from FY2024.

  • Annual Liabilities and Shareholders Equity has a five-year compound annual growth rate of 43.5% (FY2020 to FY2025).
  • Across earlier years, Liabilities and Shareholders Equity came in at $38.27 million in FY2024 (+247.3%), $11.02 million in FY2023 (-66.9%), $33.24 million in FY2022 (+30.5%) and $25.47 million in FY2021 (+72.2%).
  • Quarterly Liabilities and Shareholders Equity has ranged from $11.02 million in Q4 2023 to $99.49 million in Q3 2025 over the past five years.
  • On a year-over-year basis, Liabilities and Shareholders Equity has increased for four consecutive quarters, with growth averaging 132.2% over the last eight quarters.
  • Peak year-over-year performance for Liabilities and Shareholders Equity in the last five years was growth of 346.1% in Q3 2021, against a decline of 66.9% in Q4 2023 at the low end.
  • Per Business Quant, the preceding three quarters came in at $98.81 million (Q1 2026), $89.9 million (Q4 2025) and $99.49 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 201.06 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 135.12 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 115.83 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 49.36 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 27.42 Bn
10 vTv Therapeutics 382.70 Mn 382.70 Mn - 87.59 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 87.59 Mn
Mar 31, 2026 98.81 Mn
Dec 31, 2025 89.90 Mn
Sep 30, 2025 99.49 Mn
Jun 30, 2025 26.45 Mn
Mar 31, 2025 32.03 Mn
Dec 31, 2024 38.27 Mn
Sep 30, 2024 43.16 Mn
Jun 30, 2024 46.46 Mn
Mar 31, 2024 54.18 Mn
Dec 31, 2023 11.02 Mn
Sep 30, 2023 14.92 Mn
Jun 30, 2023 22.43 Mn
Mar 31, 2023 28.83 Mn
Dec 31, 2022 33.24 Mn
Sep 30, 2022 35.52 Mn
Jun 30, 2022 36.99 Mn
Mar 31, 2022 20.19 Mn
Dec 31, 2021 25.47 Mn
Sep 30, 2021 31.43 Mn
API Access

vTv Therapeutics Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=VTVT&period=max&api_key=YOUR_API_KEY